13801-04-2 Usage
Uses
Used in Pharmaceutical Synthesis:
1'-benzyl-[1,4'-bipiperidine]-4'-carbonitrile is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form diverse organic molecules due to the presence of the carbonitrile functional group and the benzyl group, which enhances the molecule's reactivity and stability.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1'-benzyl-[1,4'-bipiperidine]-4'-carbonitrile serves as a building block for the development of biologically active compounds, leveraging its structural features to create new molecules with potential therapeutic applications.
Used in Chemical Reactions:
1'-benzyl-[1,4'-bipiperidine]-4'-carbonitrile is utilized as a reactant in a wide range of chemical reactions owing to its stable and reactive nature, facilitating the creation of complex organic molecules for various applications in the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 13801-04-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,8,0 and 1 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 13801-04:
(7*1)+(6*3)+(5*8)+(4*0)+(3*1)+(2*0)+(1*4)=72
72 % 10 = 2
So 13801-04-2 is a valid CAS Registry Number.
13801-04-2Relevant articles and documents
Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
-
Page/Page column 72, (2008/06/13)
The present invention relates to the CGRP-antagonists of general formula I wherein R1, R2, R3 and R4 are defined as in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, as well as those compounds of general formula I wherein one or more hydrogen atoms are replaced by deuterium, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
